Fernando Azevedo Cruz Seara

Fernando Azevedo Cruz Seara

Auto-generated profile, based on publicly available information

Fernando Azevedo Cruz Seara

Center for Research in Precision Medicine, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
GMgustavo monnerat
gustavo monnerat
FSFernando A.C. Seara
Fernando A.C. Seara
JEJoseph Albert Medeiros Evaristo
Joseph Albert Medeiros Evaristo
GCGabriel Carneiro
Gabriel Carneiro
GEGeisa Paulino Caprini Evaristo
Geisa Paulino Caprini Evaristo
Antonio Carlos Campos de CarvalhoAntonio Carlos Campos de Carvalho
Antonio Carlos Campos de Carvalho

1 July 2017 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
FSFernando de Azevedo Cruz Seara
Fernando de Azevedo Cruz Seara
RBRaiana Andrade Quintanilha Barbosa
Raiana Andrade Quintanilha Barbosa
DODahienne Ferreira de Oliveira
Dahienne Ferreira de Oliveira
DSDiorney Luiz Souza Gran da Silva
Diorney Luiz Souza Gran da Silva
ACAdriana Bastos Carvalho
Adriana Bastos Carvalho
EOEmerson Lopes Olivares
Emerson Lopes Olivares

26 October 2022 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
FSFernando A. C. Seara
Fernando A. C. Seara
TKTais Hanae Kasai-Brunswick
Tais Hanae Kasai-Brunswick
JNJose Hamilton Matheus Nascimento
Jose Hamilton Matheus Nascimento
Antonio Carlos Campos de CarvalhoAntonio Carlos Campos de Carvalho
Antonio Carlos Campos de Carvalho

30 November 2020 in Hypertension
Verified
Journal Article
Closed access
PDF file
MZMario Zanaty
Mario Zanaty
FSFernando A.C. Seara
Fernando A.C. Seara
PNPablo Nakagawa
Pablo Nakagawa
GDGuorui Deng
Guorui Deng
NMNatalia M. Mathieu
Natalia M. Mathieu
CSCurt D. Sigmund
Curt D. Sigmund
Activation of central AT 1 Rs (angiotensin type 1 receptors) is required for the increased blood pressure, polydipsia, and salt intake in deoxycorticosterone acetate (DOCA)–salt hypertension. TRV120027 (TRV027) is an AT 1 R-biased agonist that selectively acts through β-arrestin. We hypothesized that intracerebroventricular administration of TRV027 would ameliorate the effects of DOCA-salt. In a neuronal cell line, TRV027 induced AT 1a R internalization through dynamin and clathrin-mediated endocytosis. We next evaluated the effect of chronic intracerebroventricular infusion of TRV027 on fluid intake. We measured the relative intake of water versus various saline solutions using a 2-bottle choice paradigm in mice subjected to DOCA with a concomitant intracerebroventricular infusion of either vehicle, TRV027, or losartan. Sham mice received intracerebroventricular vehicle without DOCA. TRV027 potentiated DOCA-induced water intake in the presence or absence of saline. TRV027 and losartan both increased the aversion for saline—an effect particularly pronounced for highly aversive saline solutions. Intracerebroventricular Ang (angiotensin) II, but not TRV027, increased water and saline intake in the absence of DOCA. In a separate cohort, blood pressure responses to acute intracerebroventricular injection of vehicle, TRV, or losartan were measured by radiotelemetry in mice with established DOCA-salt hypertension. Central administration of intracerebroventricular TRV027 or losartan each caused a significant and similar reduction of blood pressure and heart rate. We conclude that administration of TRV027 a selective β-arrestin biased agonist directly into the brain increases aversion to saline and lowers blood pressure in a model of salt-sensitive hypertension. These data suggest that selective activation of AT 1 R β-arrestin pathways may be exploitable therapeutically.

1 September 2020 in Steroids
Verified
Journal Article
Closed access
FSFernando A.C. Seara
Fernando A.C. Seara
EOEmerson L. Olivares
Emerson L. Olivares
JNJose H.M. Nascimento
Jose H.M. Nascimento

5 January 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FSFernando A. C. Seara
Fernando A. C. Seara
LMLeonardo Maciel
Leonardo Maciel
RBRaiana A. Q. Barbosa
Raiana A. Q. Barbosa
NRNayana C. Rodrigues
Nayana C. Rodrigues
ASAnderson L. B. Silveira
Anderson L. B. Silveira
EOEmerson L. Olivares
Emerson L. Olivares
Thyroid dysfunctions can increase the risk of myocardial ischemia and infarction. However, the repercussions on cardiac ischemia/reperfusion (IR) injury remain unclear so far. We report here the effects of hypothyroidism and thyrotoxicosis in the susceptibility to IR injury in isolated rat hearts compared to euthyroid condition and the potential role of antioxidant enzymes. Hypothyroidism and thyrotoxicosis were induced by administration of methimazole (MMZ, 300 mg/L) and thyroxine (T4, 12 mg/L), respectively in drinking water for 35 days. Isolated hearts were submitted to IR and evaluated for mechanical dysfunctions and infarct size. Superoxide dismutase types 1 and 2 (SOD1 and SOD2), glutathione peroxidase types 1 and 3 (GPX 1 and GPX3) and catalase mRNA levels were assessed by quantitative RT-PCR to investigate the potential role of antioxidant enzymes. Thyrotoxicosis elicited cardiac hypertrophy and increased baseline mechanical performance, including increased left ventricle (LV) systolic pressure, LV developed pressure and derivatives of pressure (dP/dt), whereas in hypothyroid hearts exhibited decreased dP/dt. Post-ischemic recovery of LV end-diastolic pressure (LVEDP), LVDP and dP/dt was impaired in thyrotoxic rat hearts, whereas hypothyroid hearts exhibited improved LVEDP and decreased infarct size. Catalase expression was decreased by thyrotoxicosis. Thyrotoxicosis was correlated, at least in part, to cardiac remodeling and increased susceptibility to IR injury possibly due to down-regulation of antioxidant enzymes, whereas hypothyroid hearts were less vulnerable to IR injury.